Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2025-04-03 00:00:00 ET · period of report 2025-04-01 · accession 0001415889-25-010007 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-04-03 | 2025-04-01 | KNSA | Paolini John F. | Chief MEDICAL Off | F - Tax | $21.77 | -991 | 56.2K | -2% | -$21.6K |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | — | +3,374 | 54.9K | +7% | — |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Paolini John F. | Chief MEDICAL Off | M - OptEx | $0.00 | -3,374 | 5,250 | -39% | $0 |
| DM | 2025-04-03 | 2025-04-01 | KNSA | Paolini John F. | Chief MEDICAL Off | A - Grant | $0.00 | +68.8K | 19.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Ordinary Share | 2025-04-01 | F | D | 514 | $21.77 | 55,639 | D | — | — | |
| 2 | Common | Class A Ordinary Share | 2025-04-01 | F | D | 477 | $21.77 | 56,153 | D | — | — | |
| 3 | Common | Class A Ordinary Share | 2025-04-01 | M | A | 1,750 | — | 56,630 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 4 | Common | Class A Ordinary Share | 2025-04-01 | M | A | 1,624 | — | 54,880 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. |
| 5 | Derivative | Restricted Share Unit | 2025-04-01 | M | D | 1,624 | $0.00 | 3,248 | D | — · — to — | 1,624 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F6) The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2023. |
| 6 | Derivative | Restricted Share Unit | 2025-04-01 | M | D | 1,750 | $0.00 | 5,250 | D | — · — to — | 1,750 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F7) The RSUs vest over a four-year period, with 25% of the RSUs vesting on the vesting commencement date of April 1, 2024, and each yearly anniversary thereafter. |
| 7 | Derivative | Share Option | 2025-04-01 | A | A | 39,364 | $0.00 | 39,364 | D | $21.77 · — to 2035-03-31 | 39,364 Class A Ordinary Share | (F2) The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 1, 2025. |
| 8 | Derivative | Restricted Share Unit | 2025-04-01 | A | A | 9,828 | $0.00 | 9,828 | D | — · — to — | 9,828 Class A Ordinary Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer. (F3) The RSUs vest over a four year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, April 1, 2025. |
| 9 | Derivative | Performance Share Unit | 2025-04-01 | A | A | 19,657 | $0.00 | 19,657 | D | — · — to — | 19,657 Class A Ordinary Share | (F4) Each Performance Share Unit (PSU) represents a contingent right to receive a number of Class A Ordinary Shares of the Issuer based upon the achievement of certain pre-established performance criteria, as certified by the Issuer's Compensation Committee (F5) Unless earlier forfeited, each PSU vests and converts into not more than 200% of one Class A Ordinary Share of the Issuer no later than January 30, 2028, unless such date falls on a non-business date, in which case the next business date shall apply. |